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ABSTRACT Inhalation of Yersinia pestis results in primary pneumonic plague, a highly lethal and rapidly progressing necrotiz-
ing pneumonia. The disease begins with a period of extensive bacterial replication in the absence of disease symptoms, followed
by the sudden onset of inflammatory responses that ultimately prove fatal. Very little is known about the bacterial and host fac-
tors that contribute to the rapid biphasic progression of pneumonic plague. In this work, we analyzed the in vivo transcription
kinetics of 288 bacterial open reading frames previously shown by microarray analysis to be dynamically regulated in the lung.
Using this approach combined with bacterial genetics, we were able to identify five Y. pestis genes that contribute to the develop-
ment of pneumonic plague. Deletion of one of these genes, ybtX, did not alter bacterial survival but attenuated host inflamma-
tory responses during late-stage disease. Deletion of ybtX in another lethal respiratory pathogen, Klebsiella pneumoniae, also
resulted in diminished host inflammation during infection. Thus, our in vivo transcriptional screen has identified an important
inflammatory mediator that is common to two Gram-negative bacterial pathogens that cause severe pneumonia.
IMPORTANCE Yersinia pestis is responsible for at least three major pandemics, most notably the Black Death of the Middle Ages.
Due to its pandemic potential, ease of dissemination by aerosolization, and a history of its weaponization, Y. pestis is categorized
by the Centers for Disease Control and Prevention as a tier 1 select agent most likely to be used as a biological weapon. To date,
there is no licensed vaccine against Y. pestis. Importantly, an early “silent” phase followed by the rapid onset of nondescript
influenza-like symptoms makes timely treatment of pneumonic plague difficult. A more detailed understanding of the bacterial
and host factors that contribute to pathogenesis is essential to understanding the progression of pneumonic plague and develop-
ing or enhancing treatment options.
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Yersinia pestis is the causative agent of plague and one of thedeadliest human pathogens. Primary pneumonic plague re-
sulting from the inhalation of Y. pestis is the most severe manifes-
tation of plague, with mortality rates approaching 100% in the
absence of timely delivery of antibiotics (1). Its low infectious
dose, capacity for aerosol transmission, and history of weaponiza-
tion have led to the classification of Y. pestis as a tier 1 select agent
requiring biosafety level 3 containment.
Our laboratory and others have characterized a mouse model
of pneumonic plague using fully virulent Y. pestis that closely
mimics human disease (2–5). Progression of pneumonic plague is
biphasic, with an initial “preinflammatory” phase in the lung
highlighted by a lack of disease symptoms or detectable host im-
mune responses. After 36 to 48 h, there is an abrupt switch to a
“proinflammatory” phase of disease characterized by the rapid
onset of symptoms, induction of proinflammatory cytokines, and
the dramatic accumulation of immune infiltrate in the airways.
Progression into the proinflammatory phase of disease leads to the
severe necrotizing pneumonia that is the hallmark of pneumonic
plague and invariably proves fatal within the following 24 to 36 h.
Little is known about the bacterial and host factors that contribute
to the progression of this disease.
Previously, our laboratory used microarray analysis to identify
410 Y. pestis genes that were significantly up- or downregulated in
the bronchoalveolar lavage fluid (BALF) of mice 48 h postinocu-
lation (hpi) compared to broth-grown culture (5). This work gave
insight into the dynamic bacterial gene expression that occurs in
the lung during infection but is only a snapshot of the syndrome at
a singular point during the proinflammatory disease phase. In the
work presented here, we implemented an in vivo transcriptional
screen to identify Y. pestis genes that contribute to the progression
of pneumonic plague. By evaluating the expression kinetics of
dynamically regulated bacterial genes in vivo and then generating
corresponding deletion mutants, we were able to identify five
genes that contribute to Y. pestis pathogenesis during pneumonic
plague. Deletion of one gene, ybtX, had no effect on bacterial or
host survival but completely altered progression into the proin-
flammatory phase of disease. Deletion of ybtX in Klebsiella pneu-
moniae, a pathogen that causes a similar necrotizing pneumonia,
also reduced inflammation during lung infection, indicating that
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ybtX may be involved in the pathogenesis of severe bacterial pneu-
monia caused by multiple species of bacteria.
RESULTS
Transcriptional analysis of highly regulated Y. pestis genes dur-
ing pulmonary infection. In 2005, Lathem et al. identified 410
Y. pestis open reading frames (ORFs) that were significantly up- or
downregulated in the bronchoalveolar lavage fluid of mice 48 h
after intranasal inoculation with Y. pestis (5). Unfortunately, per-
forming similar analysis at earlier time points proved technically
difficult. We sought to use real-time quantitative reverse tran-
scription PCR (qRT-PCR) to evaluate in detail the expression ki-
netics of highly regulated Y. pestis genes throughout the duration
of infection. We hypothesized that this analysis would reveal open
reading frames that are regulated in a phase-specific manner in the
lung, as well as genes that are highly induced at multiple time
points during infection. Phase-specific regulation or constitutive
expression may indicate that these genes are important to the pro-
gression of pneumonic plague. After elimination of a number of
metabolic genes and genes with well-defined functions, 288 Y. pes-
tis ORFs were chosen from the previous 410 genes for further
transcriptional profiling. To this end, total RNA was isolated from
the lungs of mice infected with Y. pestis CO92 at 24, 36, 48, and
60 hpi and analyzed by qRT-PCR. Fold difference was calculated
for each gene by comparing its expression to that of RNA isolated
from broth-grown culture. We focused our attention on genes
showing one of the following three patterns of transcription
(Fig. 1A): (i) gene was upregulated greater than 5-fold during at
least one of the early time points (24 h or 36 h) compared to the
later time points (48 h or 60 h), (ii) gene was upregulated greater
than 5-fold during at least one of the later time points compared to
early time points, or (iii) gene was upregulated greater than 5-fold
relative to broth-grown culture throughout the duration of infec-
tion. From this analysis, we identified 38 genes/loci of interest that
we sought to target for further analysis (see Table S1 in the sup-
plemental material).
Identification of Y. pestis genes that contribute to pneu-
monic plague. Other than the well-established type III secretion
system (T3SS), very few Y. pestis virulence determinants of pneu-
monic plague have been identified. We predicted that mutation of
ORFs demonstrating dynamic or constitutive upregulation in vivo
would reveal genes that contribute to the pathogenesis of Y. pestis
in the lung. To test this, we deleted each of the 38 genes/loci of
interest by allelic exchange mutagenesis and evaluated each mu-
tant strain in a mouse model of pneumonic plague. This analysis
identified four genes whose deletion resulted in a greater than
1-log difference in bacterial burden in the lung and/or spleen
compared to wild-type infection. Deletion of the locus YPO2349-
YPO2352 had the most dramatic effect, resulting in a greater than
4-log decrease in bacterial burden in the lung and a 3-log decrease
in the spleen (Fig. 1B). Deletion of the open reading frame
YPO0159 resulted in a similar but less dramatic effect (Fig. 1B).
Interestingly, deletion of YPO0862 had no effect on bacterial
growth in the lung but resulted in a roughly 1-log decrease in
colonization of the spleen (Fig. 1B and C). In contrast, deletion of
YPO1501 resulted in a roughly 1-log increase in colonization of
the spleen (Fig. 1C). Of the loci of interest, YPO0159 exhibited
early induction relative to the later disease phase, the YPO2349-
YPO2351 locus was induced later during disease, and YPO0862 was
highly induced throughout the duration of infection (Fig. 1D).
YPO1501 was highly induced throughout the duration of infec-
tion but also demonstrated significant upregulation early com-
pared to the later disease phase (Fig. 1D).
In summary, using in vivo analysis of bacterial gene expression
kinetics, we have identified three Y. pestis genes/loci that contrib-
ute to the pathogenesis of Y. pestis during primary pneumonic
plague and one gene whose deletion results in enhanced dissemi-
nation to the bloodstream as reflected by recovery of bacteria from
the spleen. Three of the four genes showing an in vivo phenotype
demonstrated highly increased expression throughout the dura-
tion of infection, suggesting that this pattern of expression may be
the most indicative of importance for pneumonic plague. Further
delineating the functions of these genes during pulmonary infec-
tion will help to shed light on the mechanisms underlying the
biphasic progression of pneumonic plague.
Deletion of ybtX alters progression into the inflammatory
disease phase without affecting bacterial viability. The ultimate
goal of the transcriptional analysis was to identify genes whose
deletion altered the biphasic progression of pneumonic plague. In
addition to the phenotypes described above, we observed that
mice inoculated with a strain harboring a deletion in the gene
YPO1915 (common name ybtX) showed minimal disease symp-
toms at 48 hpi compared to those inoculated with wild-type Y. pes-
tis. Whereas most animals infected with wild-type Y. pestis showed
lethargy, diminished response to stimuli, and in some cases ruffled
or matted fur, mice inoculated with the ybtX strain behaved
similarly to uninfected animals. The ybtX gene, also known as irp8,
is found within the high-pathogenicity island (HPI) of Y. pestis
responsible for the synthesis and utilization of the siderophore
yersiniabactin (Ybt), which is important for bacterial virulence
during pneumonic and bubonic plague (6–8). ybtX encodes a pre-
dicted inner membrane protein with weak similarity to importers/
exporters of siderophores in other bacteria and was recently
shown to be a Yersinia Zn2 importer (6, 7, 9). Transcription of
ybtX was found to be highly induced in the lung throughout the
duration of infection, with a greater than 100-fold increase in
expression relative to broth-grown culture during three of the
four time points tested (Fig. 2A). We anticipated that the near
absence of disease symptoms at 48 hpi would correlate with re-
duced bacterial burdens in the lungs of infected animals. Surpris-
ingly, deletion of ybtX did not alter bacterial viability in the lungs
or spleens compared to mice infected with wild-type Y. pestis
(Fig. 2B and C). Histopathological analysis of infected lungs at
48 hpi and 60 hpi during the proinflammatory disease phase re-
vealed reduced inflammatory focus formation in mice infected
with the ybtX strain compared to those infected with wild-type
Y. pestis (Fig. 2D and E). Importantly, complementation of ybtX
restored wild-type levels of inflammation in the lungs (Fig. 2D and
E). All animals eventually succumbed to disease in approximately
the same time frame, presumably due to the continued accumu-
lation of bacterial burden and the onset of lethal sepsis (Fig. 2F).
These results suggest that ybtX contributes to progression into the
proinflammatory phase of pneumonic plague.
Infection with the ybtX strain implicates a key role for neu-
trophil chemotaxis in the progression of pneumonic plague.
Transition into the proinflammatory phase of pneumonic plague
corresponds with the increased expression of proinflammatory
cytokines beginning at 36 to 48 hpi (5). As infection with the
ybtX strain showed diminished inflammation in the lungs, we
hypothesized that comparing proinflammatory cytokine induc-
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tion in ybtX mutant-infected animals with that in wild-type
Y. pestis-infected animals would reveal dysregulation of key cyto-
kines/chemokines that are important for initiating the proinflam-
matory disease phase. To test this, we evaluated the transcription
of a panel of proinflammatory cytokines/chemokines by qRT-
PCR analysis of infected lungs at 60 hpi. Transcription levels of the
proinflammatory cytokines gamma interferon (IFN-), CXCL2,
CCL3, interleukin-23 (IL-23), and tumor necrosis factor alpha
FIG 1 Identifying genes important to pneumonic plague. (A) Examples of in vivo transcription patterns of interest. Lungs from mice (n  10) infected with
Y. pestis were harvested, and 288 ORFs were evaluated by qRT-PCR. Fold difference was calculated by comparing expression to RNA isolated from broth culture
grown at 37°C for 16 h. (B) Lung bacterial burdens 48 h after infection with wild-type Y. pestis or mutant strains. (C) Spleen bacterial burdens 48 h after
inoculation with wild-type Y. pestis or mutant strains. For panels B and C, horizontal lines represent median values of data points. All mutant values were
significantly different from wild-type values via Mann-Whitney test (*, P  0.05; **, P  0.0001). (D) Expression of genes of interest shown in panels B and C
in the lung relative to broth-grown culture (data shown are from initial screen).
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FIG 2 Infection with Y. pestis ybtX mutant. (A) ybtX transcription in the lung during infection. Transcription was evaluated by qRT-PCR compared to
broth-grown culture. (B) Lung bacterial burdens in mice infected with wild-type Y. pestis CO92 or the Y. pestis ybtX mutant. (C) Spleen bacterial burdens in
mice infected with wild-type Y. pestis CO92 or the Y. pestis ybtX mutant. Panels B and C show data from a representative experiment repeated in triplicate, where
horizontal lines designate median values. (D) H&E staining of mouse lungs infected with wild-type Y. pestis, the Y. pestis ybtX mutant, and the complemented
mutant. The image is representative of an experiment performed at least three times with a minimum of three mice per strain. (E) Total area of inflammation per
lung section of infected mice. Twenty-four fields from six mice (4 fields per mouse section) per condition were analyzed to calculate average area per section using
ImageJ software. Asterisks signify statistical significance by two-way analysis of variance (P  0.005). (F) Survival of mice (n  10) infected with wild-type, ybtX,
or complemented ybtX strains. The graph is representative of an experiment repeated in triplicate. Mean time-to-death values were as follows: wild-type strain,
74 h; ybtX strain, 86 h; complemented ybtX strain, 72 h. Differences in mean time-to-death values were not statistically significant.
Pechous et al.
4 ® mbio.asm.org January/February 2015 Volume 6 Issue 1 e02302-14
(TNF-) and the anti-inflammatory cytokine IL-10 were similar
in animals infected with the ybtX mutant to those in animals
infected with wild-type Y. pestis (Fig. 3). There was a significant
decrease in the transcription of proinflammatory cytokines IL-6
and IL-17 and the chemokines CXCL1 and CCL2 in response to
infection with the ybtX strain compared to infection with wild-
type Y. pestis, indicating that these molecules may be involved in
the onset of the proinflammatory phase of pneumonic plague
(Fig. 3).
The cytokines IL-6 and IL-17 and chemokines CXCL1 and
CCL2 influence neutrophil chemotaxis during bacterial infection
(10–14). Previously, we showed that depletion of host neutrophils
prior to intranasal inoculation with Y. pestis dramatically reduced
inflammation in the lung (15). Thus, we hypothesized that the
diminished inflammatory response to infection with the ybtX
mutant would correlate with decreased neutrophil chemotaxis to
the lung. To evaluate this, we analyzed the innate immune cell
populations of the bronchoalveolar lavage fluid (BALF) of mice
inoculated with wild-type Y. pestis and the Y. pestis ybtX mutant
using flow cytometry as we have previously described (15). Dele-
FIG 3 Cytokine expression during infection. Expression of cytokines was evaluated in the lungs of mice infected with wild-type Y. pestis CO92 (wt), the ybtX
mutant, or the complemented mutant (comp ybtX) at 60 hpi compared to uninfected mice. Data shown are from two independent experiments (n  5).
Asterisks signify a significant difference for the mutant from the other two strains by two-way analysis of variance (P  0.05).
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tion of ybtX did not result in significant changes in levels of mac-
rophages, dendritic cells, or inflammatory monocytes in the air-
ways during infection (Fig. 4). In contrast, there was a significant
decrease in the levels of neutrophils found in the airways of ybtX
mutant-infected mice during the proinflammatory disease phase
by 60 hpi (Fig. 4). Complementation of the ybtX deletion restored
this neutrophil response to levels seen in infections with the wild-
type strain (Fig. 4). In summary, infection with a Y. pestis strain
lacking ybtX results in diminished neutrophil chemotaxis to the
lung, indicating that ybtX is important to initiate the intense and
ultimately lethal proinflammatory response during primary
pneumonic plague.
ybtX contributes to inflammation during pulmonary infec-
tion with Klebsiella pneumoniae. We next sought to determine if
ybtX contributes to inflammation during infection with other bac-
terial pathogens, or if this phenomenon is specific to Y. pestis. Like
Y. pestis, Klebsiella pneumoniae is a Gram-negative, extracellular
pathogen of the Enterobacteriaceae family that causes acute pneu-
monia when introduced into the lungs. K. pneumoniae is a leading
cause of Gram-negative bacterial nosocomial infections and is as-
sociated with high mortality rates (16–18). Importantly, some
strains of K. pneumoniae also harbor a functional ybt locus, in-
cluding the ybtX ORF (19, 20). To examine if ybtX plays a role in
the onset of inflammation during K. pneumoniae-induced pneu-
monia, we evaluated pulmonary infection with a ybtX strain of
K. pneumoniae VK148. Similar to Y. pestis, deletion of ybtX in
K. pneumoniae did not alter bacterial viability in the lung (Fig. 5A)
but resulted in differences in pathology during late-stage pneu-
monia (Fig. 5B and C). By 96 hpi, the lungs of mice inoculated
with wild-type K. pneumoniae showed severe edema and loss of
alveolar architecture typical of K. pneumoniae pulmonary infec-
tion (Fig. 5B). In contrast, the lungs of mice inoculated with the
K. pneumoniae ybtX mutant showed limited observable edema
with relatively intact alveolar architecture (Fig. 5B). Consistent
with a decrease in pulmonary edema, lung weights from ybtX
mutant-infected mice at 96 hpi were significantly lower than those
from mice infected with wild-type K. pneumoniae (Fig. 5C). These
results indicate that ybtX may contribute to the pathogenesis of
FIG 4 Innate immune populations in the BALF during Y. pestis infection. At 48 and 60 hpi, the bronchoalveolar lavage fluid (BALF) was collected from infected
mice (n  5) and evaluated by flow cytometry to identify innate immune populations. Data are from a single representative experiment repeated at least three
times. Populations examined were neutrophils, macrophages, monocytes, and dendritic cells (DC). The double asterisk indicates that the population is
statistically significantly different from the other two populations (P  0.05) per two-way analysis of variance.
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severe, acute pneumonia for multiple species of bacteria harbor-
ing the ybt locus.
DISCUSSION
In order to cause pneumonic plague, Y. pestis must adapt to two
very different disease phases in the lung. The first phase involves
avoiding and/or suppressing immune detection and clearance
mechanisms to allow for rapid bacterial replication, while the sec-
ond phase involves surviving the massive onslaught of host innate
immune responses. In the work presented here, we initially sought
to identify bacterial genes that demonstrated phase-specific regu-
lation during pneumonic plague and then to test their role in the
kinetics of biphasic disease progression. To this end, we analyzed
the transcription of highly regulated bacterial genes in vivo
throughout the course of infection. This represents an important
departure from the vast majority of infection transcriptional stud-
ies; rather than evaluate a single time point, our goal was to follow
the full kinetics of expression of a large number of Y. pestis genes
previously shown to be differentially regulated during the proin-
flammatory phase (5). By using RT-PCR for all time points, we
were able to assay bacterial gene expression as early as 24 hpi, when
bacterial numbers are too small to yield reliable transcriptome
data using microarray or RNA sequencing analysis of infected
lung tissue (our unpublished results).
Our analysis identified 38 genes/loci of interest that we mu-
tated and tested in a mouse model of pneumonic plague. From
this analysis, we identified three genes for which deletion resulted
in a greater than 1-log reduction of bacterial burden in the lung
and/or spleen and one for which deletion resulted in enhanced
dissemination to the bloodstream. The most striking phenotype
was observed after deletion of the YPO2349-YPO2351 locus en-
coding PspC, PspB, and PspA, all key proteins of the phage-shock
locus that has been characterized in detail in the enteric species
Yersinia enterocolitica (21, 22). This system is part of a stress re-
sponse that is essential for bacterial viability by protecting Yersinia
from damage caused by mislocalization of the secretin component
of the T3SS (21, 23). This is the first examination of this locus in
Y. pestis and highlights its importance to Yersinia pathogenesis as
well as the role that the T3SS plays during pulmonary infection.
The YPO0862 open reading frame encodes a putative protein
of unknown function that has loose identity to a helicase-like tran-
scription factor. Its deletion resulted in a roughly 1-log decrease in
bacterial burden in the spleen, suggesting a defect in dissemina-
tion from the lungs or a defect in survival in the spleen. In contrast,
deletion of YPO1501, predicted to encode a putative esterase, re-
sulted in increased numbers of bacteria in the spleen. Evaluating
the roles of both of these genes may help to identify factors impor-
tant for dissemination of Y. pestis following lung infection. Finally,
deletion of the YPO0159 open reading frame predicted to encode
the nitrite transporter NirC reduced bacterial burdens in both the
lung and the spleen. NirC has been shown to contribute to Salmo-
nella virulence in macrophages; however, its role in Yersinia spe-
cies is yet to be defined (24). Though their regulation changed
during the progression of disease, three of the four genes shown to
contribute to pathogenesis were highly induced throughout the
duration of infection, indicating that this pattern of expression
may be indicative of a role in disease. Further defining the role of
each of these genes during infection will improve our understand-
ing of the host-pathogen interactions that occur in the lung during
primary pneumonic plague.
FIG 5 K. pneumoniae ybtX strain infection. (A) Lung bacterial burden of
mice inoculated with wild-type K. pneumoniae strain VK148. Data shown are
from two individual experiments; median values are indicated by horizontal
lines. (B) H&E staining of mice inoculated with wild-type or ybtX K. pneu-
moniae. (C) Total lung weights of mice inoculated with wild-type or ybtX
K. pneumoniae. The experiment was performed in duplicate with at least five
mice. For panels A and C, mice that did not survive to the designated time
point are represented by an “X.” The asterisk signifies a significant difference
by two-way analysis of variance (P  0.05).
Novel Yersinia Mediator of Pulmonary Inflammation
January/February 2015 Volume 6 Issue 1 e02302-14 ® mbio.asm.org 7
We observed that deletion of the ybtX gene resulted in dimin-
ished disease symptoms during the proinflammatory disease
phase but had no effect on bacterial burden or dissemination.
Detailed examination of pulmonary infection with the ybtX
strain revealed reduced inflammation in the lung as demonstrated
by histopathological analysis. The ybtX open reading frame is the
third gene in the ybtPQXS operon located in the 36-kb high-
pathogenicity island (HPI) that is nearly identical in all pathogenic
Yersinia species (6, 25). With the exception of ybtD, all genes re-
quired for the regulation, synthesis, and transport of the sidero-
phore yersiniabactin (Ybt) are carried within the HPI. Y. pestis
mutants unable to transport or synthesize Ybt are attenuated in
virulence models of bubonic and pneumonic plague (8). The
products of the two genes immediately upstream of ybtX, ybtP and
ybtQ, form an inner membrane ABC transporter necessary for the
uptake of Ybt bound to iron (7). ybtS, the gene immediately down-
stream of ybtX, encodes a salicylate synthase required for the syn-
thesis of Ybt (26, 27). The ybtX open reading frame is predicted to
encode a hydrophobic inner membrane protein that belongs to
the major facilitator superfamily (MFS) (7). Deletion of ybtX in
Yersinia species has no impact on Ybt synthesis, uptake, utilization
of iron in a Ybt-dependent manner, or virulence in mice (7, 28).
This is somewhat surprising, as deletion of any of the other ybt
genes within the HPI results in attenuated bacterial growth in the
absence of iron and during infection.
Recently, YbtX was shown to be involved in the import of Zn2
in Y. pestis (9). Bobrov et al. showed that yersiniabactin is required
for growth of Y. pestis under Zn2-deficient conditions in strains
lacking the zinc acquisition locus ZnuABC and that zinc acquisi-
tion under these circumstances was dependent on yersiniabactin
and YbtX (9). Our results are the first to identify a role for ybtX in
disease. These results suggest a potential link between zinc in the
induction of inflammatory responses in the lung during primary
pneumonic plague. The anti-inflammatory effects of zinc within
the airways have been known for some time, and it is understood
that zinc deficiency in tissues can be highly inflammatory, partic-
ularly during infection (29–33). Thus, the role of ybtX in import-
ing zinc may alter host immunity and contribute to inflammation
within the lung.
The severely diminished host response in the lung allowed for
use of the ybtX strain to probe the mouse model of pneumonic
plague to identify key host mediators of inflammation. qRT-PCR
evaluation revealed the decreased transcription of key proinflam-
matory cytokines IL-6 and IL-17 and the chemokines CXCL1 and
CCL2 in the lungs of mice infected with ybtX, indicating that
these cytokines and chemokines may be important to the biphasic
progression of pneumonic plague. This is the first study to pin-
point cytokines/chemokines that may be of specific importance to
the transition to the proinflammatory phase of pneumonic
plague. IL-6 is a pleiotropic cytokine involved in the induction of
fever and stimulation of acute-phase responses, as well as neutro-
phil production in the bone marrow (34–36). IL-6 is an estab-
lished biomarker of pneumonia (37) and has been previously
shown to be highly induced during pneumonic plague (4, 5).
IL-17 is a proinflammatory cytokine known to be involved in host
defense against a variety of microbes and is important for recruit-
ing neutrophils to mucosal surfaces (11, 38, 39). IL-17 has been
shown to be highly induced during pneumonic plague and is also
speculated to be involved in cell-mediated defense against Yersinia
infection (4, 5, 12, 40). The chemokine CCL2, otherwise known as
MCP-1, is an important chemoattractant for monocytes, macro-
phages, and neutrophils to sites of inflammation (41, 42). CCL2 is
highly induced during pneumonic plague, and it has been sug-
gested that CCL2 interactions with its receptor on innate immune
cells are important for defense against Y. pestis and are thus tar-
geted for inhibition by the Yersinia T3SS (5, 43, 44). CXCL1 is a
known chemoattractant of neutrophils that has been shown to be
induced during Yersinia infection (45, 46). A common function of
these four molecules is the recruitment of neutrophils to sites of
inflammation, and their dysregulation in response to pulmonary
infection with ybtX suggests an impaired ability to stimulate
neutrophil chemotaxis to the lung. Design of treatments aimed at
blocking these chemokines/cytokines, with the goal of limiting
neutrophil accumulation in the lung, may aid in expanding the
short time window during which antibiotic treatment is effective
against pneumonic plague.
Infection with a ybtX strain revealed a significant and strik-
ingly specific decrease in the number of neutrophils in the airways,
indicating that YbtX is involved in initiating host responses that
stimulate neutrophil migration to the lung. Previously, we showed
that antibody-mediated depletion of neutrophils prior to inocu-
lation with Y. pestis resulted in significantly diminished inflamma-
tion in the lung, ultimately attenuating pneumonia without alter-
ing bacterial survival (15). Here, we demonstrate deletion of a
bacterial gene that results in a similar effect. Together, these data
highlight that the pathology of pneumonic plague is largely host
mediated, the consequence of recruitment of neutrophils to the
lung and their continued accumulation in the airways. Further,
this response does not appear to be dependent solely on a thresh-
old of bacterial burden in the lung, as deletion of ybtX attenuated
host inflammatory responses without affecting bacterial burden.
The unchanged bacterial burdens in the lung and spleen despite a
severely hindered neutrophil response indicate that neutrophils
play a limited role in controlling Y. pestis during pulmonary infec-
tion and are thus highly damaging to the host without any imme-
diately obvious benefit. Therefore, the ability of Y. pestis to resist
neutrophil-mediated killing is likely key to the progression of
pneumonic plague.
Deletion of ybtX also altered infection with K. pneumoniae,
resulting in decreased inflammation as indicated by histopatho-
logical examination and decrease in lung weight compared to
wild-type-infected lungs. K. pneumoniae also causes severe acute
pneumonia, albeit via different mechanisms. Infection with
K. pneumoniae leads to early inflammatory responses in the lung
that ultimately result in severe edema and a near-complete loss of
alveolar architecture in localized areas in the lung. The finding
that ybtX contributes to this response is intriguing and indicates
that its function may be conserved among a number of bacterial
species that cause pneumonia and carry the ybt gene locus. This is
important, as evaluating the role of ybtX may help to elucidate the
mechanisms that contribute to the onset of severe pneumonia
caused by multiple pathogens and may represent a point for ther-
apeutic targeting.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The fully virulent Yersinia pestis
strain CO92 was obtained from the U.S. Army, Fort Detrick, MD. Y. pestis
strains were grown on brain heart infusion (BHI) agar (Difco Laborato-
ries) at 26°C for 2 days. For infections, liquid cultures of Y. pestis CO92
were grown in BHI broth for 6 to 12 h at 26°C. The cultures were then
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diluted to an optical density at 620 nm (OD620) of 0.05 to 0.1 in BHI
supplemented with 2.5 mM CaCl2 and grown for 12 to 16 h at 37°C with
constant shaking.
VK148, a streptomycin- and rifampin-resistant mutant of K. pneu-
moniae ATCC 43816, was grown on LB agar with 30 g/ml rifampin at
26°C for 24 h. For infections, a liquid culture of K. pneumoniae was grown
in LB broth overnight at 37°C.
Deletion and complementation of ybtX. For Y. pestis, the ybtX open
reading frame was deleted using a modified form of lambda red recombi-
nation described by Lathem et al. (47). Briefly, upstream and downstream
sequences of ybtX were amplified and combined in splicing by overhang
extension (SOE) PCRs with a Kanr cassette flanked by FLP recombination
target (FRT) sites (48) for allelic replacement of the wild-type ybtX ORF.
The Kanr cassette was resolved by the introduction of pSkippy, a Tets
derivative of pFLP3 (49) harboring an Ampr cassette and sacB and carry-
ing the FLP recombinase gene under the control of the lac promoter.
A complementing strain for ybtX was constructed by using Tn7-
based integration of the ybtX open reading frame under the control of the
ybtPQXS promoter in single copy into the chromosomal glmS-pstS inter-
genic region. Briefly, the ybtX open reading frame was cloned immediately
downstream of the ybtPQXS promoter in the multiple-cloning site of
pUC18R6K-mini-Tn7T-Kan (49). The resulting plasmid was electropo-
rated along with pTNS2 (49), a plasmid carrying the TnsABCD specific
transposition pathway, into the ybtX strain, and transformants were
selected on BHI plates containing kanamycin. The Kanr cassette was then
resolved via the introduction of pSkippy as described above.
For K. pneumoniae, the ybtX open reading frame was deleted using
double recombination as previously described (50). Briefly, approxi-
mately 1-kb upstream and downstream flanking regions of the ybtX gene
were PCR amplified and combined using SOE PCR for cloning into the
pKAS46 vector. The resulting vector was mated into K. pneumoniae, and
merodiploids were selected on LB agar with rifampin (30 g/ml) and
kanamycin (50 g/ml). Merodiploids were grown in LB broth without
antibiotics for ~4 h and then plated on LB agar with streptomycin (1 mg/
ml). Kanamycin-susceptible colonies were tested by colony PCR for loss
of the ybtX gene before sequencing to confirm deletion.
Animals and animal infections. All animal studies were approved by
the University of North Carolina at Chapel Hill Office of Animal Care and
Use, protocol 09-057. Six- to 8-week-old female C57BL/6J mice were ob-
tained from Jackson Laboratories. Mice were provided with food and
water ad libitum and maintained at 25°C and 15% humidity with alter-
nating 12-h periods of light and dark. For animal infections, groups of
four to five mice were lightly anesthetized with ketamine-xylazine and
inoculated intranasally with a lethal dose of bacteria suspended in 20 l
phosphate-buffered saline (PBS); a dose of 104 CFU was used for Y. pestis
and 105 was used for K. pneumoniae. Moribund animals were euthanized
with an overdose of sodium pentobarbital. For determination of bacterial
burden, lungs or spleens were removed at the indicated times and homog-
enized in 1 ml PBS using an Omni Tissue Tearer. Serial dilutions of each
organ homogenate were plated on BHI agar (for Y. pestis) or LB agar with
rifampin (30 g/ml, for K. pneumoniae) and reported as CFU/organ.
Survival curves. For analysis of survival kinetics, mice were inoculated
with 104 CFU of Y. pestis CO92 or ybtX mutant. Mice were monitored
twice daily and were euthanized with an overdose of sodium pentobarbital
when moribund. Remaining mice were euthanized at the termination of
the experiment.
Histopathology. Groups of three to four mice were inoculated intra-
nasally as described above, and lungs were inflated with 1 ml of 10%
neutral buffered formalin via tracheal cannulation and then removed and
incubated in 10% formalin for a minimum of 24 h. Lungs were washed
once in PBS for 2 h, immersed in 70% ethyl alcohol (EtOH), and embed-
ded in paraffin. Three 5-micrometer sections 200 m apart per lung were
stained with hematoxylin-eosin (H&E) for examination.
For quantitation of histopathology, four images were taken at 4
magnification of a single H&E-stained lung section from each of six ani-
mals (from two independent experiments) infected with either wild-type
Y. pestis, Y. pestis ybtX mutant, or complemented Y. pestis ybtX mutant
at 48 and 60 hpi. Inflammatory foci were encircled, and pixel area was
measured using ImageJ software (at 4 magnification; 5.48 pixels 
10 m). The 24 fields per condition (infecting strain and time point) were
averaged to yield the average area of inflammation per mouse section.
Analysis of bacterial gene expression in vivo. In order to evaluate
Y. pestis gene expression in the lungs of infected mice, two identical ex-
periments were performed as follows: groups of mice were inoculated
intranasally with 1  104 CFU of Y. pestis CO92, and at 24, 36, 48, and 60 h,
lungs were harvested from five mice, submerged immediately in 10 ml of
RNAlater solution (Ambion), and stored at 4°C for 24 h. Lungs were then
transferred to 10 ml TRIzol and homogenized with an Omni Tissue
Tearer. Total RNA was then isolated per the manufacturer’s instructions
and treated with DNase I (Ambion). For an in vitro sample for compari-
son, total RNA was also isolated from 1 ml Y. pestis culture grown for 16 h
at 37°C in the presence of 2.5 mM CaCl2. Five micrograms of RNA was
then used to generate cDNA using the Superscript III polymerase (Invit-
rogen) along with genome-directed primers specific for DNA upstream of
each Y. pestis CO92 ORF (Washington University sequencing facility).
cDNAs were then used as the templates for amplification and detection of
the 288 Y. pestis target genes with SYBR green dye (Bio-Rad) in an iCycler
thermocycler (Bio-Rad). For each gene, the calculated threshold cycle
(CT) was normalized to the CT of the gyrB gene from the same sample
before calculating fold change relative to sample isolated from broth-
grown culture using the CT method (51, 52).
Cytokine analysis. Groups of five mice were inoculated intranasally
with 1  104 CFU of Y. pestis CO92, Y. pestis CO92 ybtX, or the comple-
mented Y. pestis CO92 ybtX. Uninfected mice and mice infected for 24,
48, and 60 h were sacrificed, and the lungs were removed, immediately
minced, and submerged in 2 ml of TRIzol reagent (Ambion). Lungs were
then homogenized with an Omni Tissue Tearer. Total RNA was purified
from lung homogenates using the TRIzol reagent manufacturer protocol,
treated with Turbo DNase (Ambion), and reverse transcribed with the
iScript cDNA synthesis kit (Bio-Rad) according to the manufacturer’s
instructions. cDNAs were used as the templates for amplification and
detection of the mouse genes encoding IL-17, IL-6, IL-23, TNF-, IFN-,
CCL2, CCL3, CXCL1, CXCL2, IL-10, and IL-12 and with SYBR green dye
(Bio-Rad) in an iCycler thermocycler (Bio-Rad). For each gene, the cal-
culated threshold cycle (CT) was normalized to that of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) from the same sample prior to cal-
culating the fold change using the CT method (51, 52).
Lavage of lungs for flow cytometry. For generating a lung single-cell
suspension of the BALF, mice were euthanized with an overdose of so-
dium pentobarbital, and the hepatic portal vein was cut and bled. The
tracheas were cannulated with a 22-gauge catheter, and lungs were in-
flated with 1 ml PBS using a 1-ml syringe, which was then drawn out
slowly. This was repeated twice for a total of 3 ml. BALF suspensions were
spun at 500  g for 5 min at 4°C and then resuspended in 1 ml red blood
cell lysis solution (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). After
incubation at room temperature for 1 min, 9 ml PBS was added and cells
were pelleted as described above for staining.
Staining of lung cell suspensions for flow cytometry. After red blood
cell lysis, cell suspensions from each animal were resuspended in 100 l of
2.4G2 hybridoma supernatant and incubated at room temperature for 20
min to block macrophage Fc receptors. Cell suspensions were then pel-
leted at 500  g for 5 min at 4°C. Cells were resuspended and incubated for
30 min at 4°C with the following fluorescently labeled antibodies in flow
cytometry buffer (2% fetal bovine serum in PBS) for staining of cell sur-
face markers (1:500 dilutions): CD11b-phycoerythrin (clone M1/70.15;
Invitrogen), CD11c-phycoerythrin-Texas Red (clone N418; Invitrogen),
Ly-6G-phycoerythrin-Cy7 (clone 1A8; BD Bioscience), LIVE/DEAD fix-
able aqua dead cell stain (clone L34957; Invitrogen), and F4/80-
allophycocyanin (clone BM8; BioLegend). Stained cells were analyzed
based on fluorescence staining patterns to identify alveolar macrophages
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(F4/80 CD11bmid/low CD11chigh), CD11bhigh interstitial/exudate macro-
phages (F4/80 CD11bhigh CD11clow/mid), monocytes (F4/80
CD11bhigh CD11clow Ly-6G), CD11bhigh and CD11blow dendritic cells
(F4/80 CD11chigh CD11bhigh or low), and neutrophils (F4/80 CD11clow
CD11bhigh Ly-6G) (15). Five hundred microliters of PBS was then added
to samples, followed by centrifugation at 500  g at 4°C. Cell suspensions
were then resuspended in 2% formalin and incubated at room tempera-
ture for 15 min for fixation, followed by centrifugation and resuspension
in PBS with gentamicin (100 g/ml) for removal from the biosafety level
3 laboratory.
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